Skip to content
AnalystLens
Back to MRNABalance Sheet

Moderna, Inc. Current Assets 2017-2026 | MRNA

Annual FY2017–FY2025 · quarterly through Q1 FY2026

Latest annual · FY2025

$6.54B

−19.2%YoY vs FY2024Source: 10-KFY2025

From $783.2M in FY2017 to $6.54B in FY2025: 8.4× in 8 years.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY26$5.8B−14.7%Not reportedNot reportedNot reported
FY25$6.8B−29.5%$6.2B−36.1%$6.6B−31.7%$6.5B−19.2%
FY24$9.6B−20.8%$9.7B−8.8%$9.7B−10.5%$8.1B−21.6%
FY23$12.1B−25.9%$10.6B−21.9%$10.8B−24.5%$10.3B−23.1%
FY22$16.4B+39.7%$13.6B+23.6%$14.3B+6.5%$13.4B−16.4%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date.

Key Statistics

Trend DirectionDeclining
CAGR

+0.8%

FY2020
$6.30B
FY2025
$6.54B

5 years selected · on the chart

Current Assets History

Year-over-year comparison from 10-K annual reports

  1. $6.54B
YoY changeLargest recent move+457.9%in FY20Latest −19.2%

2 older moves run past ±150% (largest +457.9%); point at, tap or drag across the bars to read one.

Current Assets, period by period

PeriodValueChangeSource
FY2025$6.54B−19.2%10-K
FY2024$8.10B−21.6%10-K
FY2023$10.32B−23.1%10-K
FY2022$13.43B−16.4%10-K
FY2021$16.07B+155.2%10-K
FY2020$6.30B+457.9%10-K
FY2019$1.13B−27.8%10-K
FY2018$1.56B+99.6%10-K
FY2017$783.2M—10-K

What is current assets?

Current assets are resources expected to be converted to cash or consumed within one year or the normal operating cycle of the business.

What is Moderna, Inc.'s current current assets?

Moderna, Inc. (MRNA) annual current assets for 2025 was $6.54B, a 19.20% decline from 2024. Moderna, Inc. current assets for the quarter ending March 31, 2026 was $5.77B.

What was Moderna, Inc.'s current assets in 2024?

Moderna, Inc. annual current assets for 2024 was $8.10B, a 21.56% decline from 2023.

What was Moderna, Inc.'s current assets in 2023?

Moderna, Inc. annual current assets for 2023 was $10.32B, a 23.13% decline from 2022.

What is Moderna, Inc.'s 5-year current assets CAGR?

Moderna, Inc. current assets grew at a compound annual growth rate (CAGR) of 0.77% from FY2020 to FY2025, going from $6.30B to $6.54B over 5 years.

Company
Moderna, Inc.
Ticker
MRNA
Sector
Healthcare
Industry
Biological Products, (No Diagnostic Substances)